| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Cue Biopharma, Inc.'s insiders have reduced their positions by a net 86,790 shares worth roughly $2.4M. In the past 30 days, 0 insiders bought and 3 sold.
All 3 insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 694.9K | $14.50M | -11,087 | |
| Other | 116.7K | $2.43M | -1,844 | |
| VP | 47.8K | $997.5K | -1,144 | |
| Dir | 32.6K | $679.9K | - | |
| Other | 31.5K | $657.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 24, 2018 | Anthony Digiandomenico | Director | Buy | 10,000 | $4.81 | $48,100.00 | +50.0% | |
| Dec 21, 2018 | Anthony Digiandomenico | Director | Buy | 10,000 | $4.49 | $44,900.00 | +100.0% | |
| Dec 21, 2018 | Anish Suri69 | Chief Scientific Officer | Buy | 2,000 | $4.37 | $8,740.00 | New | |
| Dec 21, 2018 | Christopher A Marlett | Director | Buy | 17,200 | $4.53 | $77,916.00 | +50.2% | |
| Dec 20, 2018 | Christopher A Marlett | Director | Buy | 9,438 | $4.74 | $44,736.12 | +38.1% | |
| Dec 19, 2018 | Christopher A Marlett | Director | Buy | 400 | $5.00 | $2,000.00 | +1.6% | |
| Dec 18, 2018 | Christopher A Marlett | Director | Buy | 3,664 | $5.20 | $19,052.80 | +17.7% | |
| Dec 17, 2018 | Anthony Digiandomenico | Director | Buy | 10,000 | $5.48 | $54,800.00 | New | |
| Dec 13, 2018 | Christopher A Marlett | Director | Buy | 10,000 | $5.06 | $50,600.00 | +93.2% | |
| Dec 12, 2018 | Christopher A Marlett | Director | Buy | 12,189 | $5.08 | $61,978.23 | -836.6% |